What is Naltrexone?

Naltrexone Molecule Structure

Naltrexone is an opiate receptor antagonist. The 50mg dose of Naltrexone was approved by the FDA for opioid and alcohol addiction in 1984. At much lower doses (0.5-9mg per day), it may provide relief to patients suffering from autoimmune diseases, chronic pain, mental health diseases, and inflammation.

Low Dose Naltrexone vs. Ultra-Low Dose Naltrexone:

Ultra-Low Dose Naltrexone (ULDN) is typically doses between one and ten micrograms (mcg). Low Dose Naltrexone (LDN) includes milligram (mg) doses from 0.5 mg – 4.5 mg.

LDN Rx Consultant

YOUR Naltrexone Experts!

The LDN Rx Consultants are a group of physicians, pharmacists, and researchers across the country dedicated to staying up to date on the latest research being released about finding therapeutic success with LDN and ULDN.

Michelle Moser, RPh is YOUR local Naltrexone expert.

When working with an LDN Rx Consultant, a nation-wide community dedicated to continuing education and developing treatment protocols to find relief for patients is at your disposal.

LDNRx Consultants logo

Already using LDN or ULDN?

We want to hear your story!

“I highly recommend LDN to anyone dealing with autoimmune conditions. It’s reduced the inflammation I had throughout my body and is allowing my body to finally heal. So happy!”

– Rachel M.

LDNscience.org

Who is a good candidate for Low Dose Naltrexone?

  • ALS (Lou Gehrig’s Disease)
  • Addiction
  • Addison’s Disease
  • Alopecia Areata
  • Alzheimer’s Disease
  • Amyotrophic Lateral Sclerosis
  • Ankylosing Spondylitis
  • Anxiety
  • Atopic Allergy
  • Atopic Dermatitis
  • Autism Spectrum Disorders
  • Bechet’s Disease
  • Benign Prostatic Hypertrophy (BPH)
  • Brain Fog
  • COPD
  • CREST Syndrome
  • Celiac Disease
  • Chronic Fatigue Syndrome
  • Complex Regional Pain Syndrome
  • Crohn’s Disease
  • Depression
  • Dermatomyositis
  • Diabetes Mellitus Type I
  • Eczema
  • Ehlers-Danlos Syndrome
  • Endometriosis
  • Fibromyalgia
  • General Anxiety Disorder
  • Granulomatosis
  • Graves Disease
  • HIV/AIDS
  • Hailey-Hailey Disease
  • Hashimoto’s Disease
  • Hypothyroidism
  • Irritable Bowel Syndrome (IBS)
  • Kawasaki’s Disease
  • Lupus
  • Lyme Disease
  • Menier’s Disease
  • Migraine Headaches
  • Multiple Sclerosis (MS)
  • Obsessive Compulsive Disorder (OCD)
  • Pandas Disease
  • Parkinson’s Disease
  • Pediatrics
  • Pemphigoid
  • Periodontal Disease
  • Polycystic Ovary Syndrome (PCOS)
  • Post-Traumatic Stress Disorder (PTSD)
  • Primary Lateral Sclerosis (PLS)
  • Psoriasis
  • Psoriatic Arthritis
  • Restless Leg Syndrome
  • Rheumatoid Arthritis
  • SIBO
  • Sarcoidosis
  • Scleroderma
  • Sjogren’s Syndrome
  • Stiff Person Syndrome (SPS)
  • Transverse Myelitis
  • Ulcerative Colitis
  • Wegener’s
  • Weight Loss
  • Women’s Health
  • Vitiligo

Dosing Guidelines

It is critical to work with a provider or an accredited compounding pharmacy knowledgable in strategies that can help ensure success in using LDN. Optimal dosing is ultimately patient specific. Some patients find success very quickly, while others need to try a variety of dosing strategies while working closely with their provider and pharmacist.

To start out, we offer two different LDN capsule titration kits. Each kit increases the dose slowly by only 0.5 mg each week, until the patient’s therapeutic dose is reached. These titration kits range from either 0.5-4.5 mg or 1.5-4.5 mg of Naltrexone. Please consult with your health care provider to determine the best treatment plan for you.

In addition to capsules, LDN can also be compounded into a flavored oral suspension (almond, olive, and MCT oil bases) as well as a transdermal cream (various cream bases available).

Low Dose Naltrexone vs. Ultra-Low Dose Naltrexone:

Ultra-Low Dose Naltrexone (ULDN) is typically doses between one and ten micrograms (mcg). On the other hand, Low Dose Naltrexone (LDN) includes milligram (mg) doses from 0.5 mg – 4.5 mg.

These dosing guidelines are generalized for the purposes of clarity. Every patient is different, and we specialize in catering to each individuals’ needs when finding the right dose of Naltrexone. Contact our pharmacists for more information!

Learn More

LDN Radio Show:

The LDN Radio show where Michelle Moser talks about why she is so excited about the possibilities and potential uses of LDN. It’s so important to work with a pharmacy that understands your needs, as well as being experienced at helping patients find therapeutic success with their LDN treatment protocols!

Upcoming Events

See the list below for a list of our LDN Seminar Dates, or click the button below to view the full calendar!

October LDN Seminar

This video is a recorded livestream of our LDN & CBD Provider Seminar, held at our pharmacy location in downtown Mount Vernon on October 22nd, 2019!

Other Resources:

Learn about LDN resources available to you. For example, upcoming LDN talks, newer clinical studies, and much more – straight from the source!

"The LDN Book" Written by the founder of the low dose naltrexone research trust, Linda Elsegood